Phase I trial of daily subcutaneous SPL-108 injections in combination with paclitaxel in patients with platinum resistant CD44+ advanced ovarian epithelial cancerEugenia Girda, Lorna Rodrı́guez-Rodrı́guez|International Journal of Gynecological Cancer|2022Cited by 14
Targeting CA-125 Transcription by Development of a Conditionally Replicative Adenovirus for Ovarian Cancer TreatmentEr Yue, Edward Wenge Wang, Yuanfei Yao et al.|Cancers|2021Cited by 11